FemTech

There is a growing market for digital health technologies geared towards women, or FemTech. Popular examples of FemTech include menstruation tracking apps and innovations like biodegradable, flushable at-home pregnancy tests. Funding for the FemTech industry, which began in the 2010s, was slowly on the rise until the pandemic hit in 2020, and by January 202,2, investments had skyrocketed. In 2024, this sector was estimated to be worth $55.9 billion, with anticipated growth to about $130.8 billion in 2034.

Privacy and surveillance concerns — especially after the U.S. Supreme Court overturned Roe v. Wade in 2022, which prompted warnings to women in pro-life states to stop using menstruation tracking apps — could be a disruptor to this burgeoning market. However, FemTech's growth shows that gender considerations in health care are becoming a social priority.